STENOCARE A/S Logo

STENOCARE A/S

Develops and distributes prescription medical cannabis oils in Northern Europe and Australia.

STENO | ST

Overview

Corporate Details

ISIN(s):
DK0061078425
LEI:
549300NCH67H3GA28R82
Country:
Denmark
Address:
Nyholmsvej 4, 8930 Randers NØ
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

STENOCARE A/S is a pharmaceutical company that develops, produces, and distributes prescription-based medical cannabis products. The company focuses on providing pharmaceutical-grade cannabis oils, ensuring quality and uniformity for patients treating various conditions. A pioneer in the field, STENOCARE was the first to supply approved medical cannabis oil products in several Nordic countries. It operates under strict regulatory controls, holding permits for cultivation, handling, and distribution. The company serves patients and doctors across markets in Northern Europe and Australia, aiming to enhance quality of life through well-documented and accessible medical cannabis solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all STENOCARE A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for STENOCARE A/S

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for STENOCARE A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France
ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden
ABLI
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America
ABP
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France
AB
ACADIA PHARMACEUTICALS INC Logo
Develops and commercializes innovative therapies for CNS disorders and rare diseases.
United States of America
ACAD
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America
ACRS
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America
ATNM

Talk to a Data Expert

Have a question? We'll get back to you promptly.